title: Intermittent androgen suppression--ready for prime time?
authors.forename: Joseph
authors.initials: J
authors.lastname: Ischia
authors.forename: S Larry
authors.initials: SL
authors.lastname: Goldenberg
mesh_terms: D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D005485:Flutamide / Q000008:administration & dosage*; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D019529:Sexuality / Q000187:drug effects*; D013739:Testosterone / Q000037:antagonists & inhibitors*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D013739:Testosterone; D005485:Flutamide; D016729:Leuprolide